371 related articles for article (PubMed ID: 24719095)
1. Mutation of putative GRK phosphorylation sites in the cannabinoid receptor 1 (CB1R) confers resistance to cannabinoid tolerance and hypersensitivity to cannabinoids in mice.
Morgan DJ; Davis BJ; Kearn CS; Marcus D; Cook AJ; Wager-Miller J; Straiker A; Myoga MH; Karduck J; Leishman E; Sim-Selley LJ; Czyzyk TA; Bradshaw HB; Selley DE; Mackie K
J Neurosci; 2014 Apr; 34(15):5152-63. PubMed ID: 24719095
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid Tolerance in S426A/S430A x
Piscura MK; Sepulveda DE; Maulik M; Guindon J; Henderson-Redmond AN; Morgan DJ
J Pharmacol Exp Ther; 2023 Apr; 385(1):17-34. PubMed ID: 36669876
[TBL] [Abstract][Full Text] [Related]
3. Tolerance to WIN55,212-2 is delayed in desensitization-resistant S426A/S430A mice.
Nealon CM; Henderson-Redmond AN; Hale DE; Morgan DJ
Neuropharmacology; 2019 Apr; 148():151-159. PubMed ID: 30629988
[TBL] [Abstract][Full Text] [Related]
4. Sex-specific mechanisms of tolerance for the cannabinoid agonists CP55,940 and delta-9-tetrahydrocannabinol (Δ
Henderson-Redmond AN; Sepulveda DE; Ferguson EL; Kline AM; Piscura MK; Morgan DJ
Psychopharmacology (Berl); 2022 May; 239(5):1289-1309. PubMed ID: 34165606
[TBL] [Abstract][Full Text] [Related]
5. Mice Expressing a "Hyper-Sensitive" Form of the Cannabinoid Receptor 1 (CB1) Are Neither Obese Nor Diabetic.
Marcus DJ; Zee ML; Davis BJ; Haskins CP; Andrews MJ; Amin R; Henderson-Redmond AN; Mackie K; Czyzyk TA; Morgan DJ
PLoS One; 2016; 11(8):e0160462. PubMed ID: 27501235
[TBL] [Abstract][Full Text] [Related]
6. Sex differences in antinociceptive response to Δ-9-tetrahydrocannabinol and CP 55,940 in the mouse formalin test.
LaFleur RA; Wilson RP; Morgan DJ; Henderson-Redmond AN
Neuroreport; 2018 Apr; 29(6):447-452. PubMed ID: 29461336
[TBL] [Abstract][Full Text] [Related]
7. c-Jun N terminal kinase signaling pathways mediate cannabinoid tolerance in an agonist-specific manner.
Henderson-Redmond AN; Nealon CM; Davis BJ; Yuill MB; Sepulveda DE; Blanton HL; Piscura MK; Zee ML; Haskins CP; Marcus DJ; Mackie K; Guindon J; Morgan DJ
Neuropharmacology; 2020 Mar; 164():107847. PubMed ID: 31758947
[TBL] [Abstract][Full Text] [Related]
8. Sex Differences in Tolerance to Delta-9-Tetrahydrocannabinol in Mice With Cisplatin-Evoked Chronic Neuropathic Pain.
Henderson-Redmond AN; Crawford LC; Sepulveda DE; Hale DE; Lesperance JJ; Morgan DJ
Front Mol Biosci; 2021; 8():684115. PubMed ID: 34250019
[TBL] [Abstract][Full Text] [Related]
9. Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors.
Smith PA; Selley DE; Sim-Selley LJ; Welch SP
Eur J Pharmacol; 2007 Oct; 571(2-3):129-37. PubMed ID: 17603035
[TBL] [Abstract][Full Text] [Related]
10. Mice expressing a "hyper-sensitive" form of the CB1 cannabinoid receptor (CB1) show modestly enhanced alcohol preference and consumption.
Marcus DJ; Henderson-Redmond AN; Gonek M; Zee ML; Farnsworth JC; Amin RA; Andrews MJ; Davis BJ; Mackie K; Morgan DJ
PLoS One; 2017; 12(4):e0174826. PubMed ID: 28426670
[TBL] [Abstract][Full Text] [Related]
11. Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization.
Jin W; Brown S; Roche JP; Hsieh C; Celver JP; Kovoor A; Chavkin C; Mackie K
J Neurosci; 1999 May; 19(10):3773-80. PubMed ID: 10234009
[TBL] [Abstract][Full Text] [Related]
12. β-arrestin2 regulates cannabinoid CB1 receptor signaling and adaptation in a central nervous system region-dependent manner.
Nguyen PT; Schmid CL; Raehal KM; Selley DE; Bohn LM; Sim-Selley LJ
Biol Psychiatry; 2012 Apr; 71(8):714-24. PubMed ID: 22264443
[TBL] [Abstract][Full Text] [Related]
13. Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons.
Laprairie RB; Bagher AM; Kelly ME; Dupré DJ; Denovan-Wright EM
J Biol Chem; 2014 Sep; 289(36):24845-62. PubMed ID: 25037227
[TBL] [Abstract][Full Text] [Related]
14. Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1/2 MAP kinase signaling.
Daigle TL; Kearn CS; Mackie K
Neuropharmacology; 2008 Jan; 54(1):36-44. PubMed ID: 17681354
[TBL] [Abstract][Full Text] [Related]
15. Reduced Tolerance and Asymmetrical Crosstolerance to Effects of the Indole Quinuclidinone Analog PNR-4-20, a G Protein-Biased Cannabinoid 1 Receptor Agonist in Mice: Comparisons with Δ
Ford BM; Cabanlong CV; Tai S; Franks LN; Penthala NR; Crooks PA; Prather PL; Fantegrossi WE
J Pharmacol Exp Ther; 2019 May; 369(2):259-269. PubMed ID: 30833484
[TBL] [Abstract][Full Text] [Related]
16. Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal.
Deng L; Guindon J; Cornett BL; Makriyannis A; Mackie K; Hohmann AG
Biol Psychiatry; 2015 Mar; 77(5):475-87. PubMed ID: 24853387
[TBL] [Abstract][Full Text] [Related]
17. Delta FosB and AP-1-mediated transcription modulate cannabinoid CB₁ receptor signaling and desensitization in striatal and limbic brain regions.
Lazenka MF; David BG; Lichtman AH; Nestler EJ; Selley DE; Sim-Selley LJ
Biochem Pharmacol; 2014 Oct; 91(3):380-9. PubMed ID: 25093286
[TBL] [Abstract][Full Text] [Related]
18. Lack of hippocampal CB1 receptor desensitization by Δ(9)-tetrahydrocannabinol in aged mice and by low doses of JZL 184.
Feliszek M; Bindila L; Lutz B; Zimmer A; Bilkei-Gorzo A; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):603-12. PubMed ID: 26984820
[TBL] [Abstract][Full Text] [Related]
19. Disruption of hippocampal synaptic transmission and long-term potentiation by psychoactive synthetic cannabinoid 'Spice' compounds: comparison with Δ
Hoffman AF; Lycas MD; Kaczmarzyk JR; Spivak CE; Baumann MH; Lupica CR
Addict Biol; 2017 Mar; 22(2):390-399. PubMed ID: 26732435
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid receptor-interacting protein 1a modulates CB1 receptor signaling and regulation.
Smith TH; Blume LC; Straiker A; Cox JO; David BG; McVoy JR; Sayers KW; Poklis JL; Abdullah RA; Egertová M; Chen CK; Mackie K; Elphick MR; Howlett AC; Selley DE
Mol Pharmacol; 2015 Apr; 87(4):747-65. PubMed ID: 25657338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
